Key Trends and Insights into the Preclinical CRO Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the preclinical cro market grown over the years?
In the past few years, there has been a significant expansion in the size of the preclinical CRO market. The market is set to increase from $5.7 billion in 2024 to $6.26 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to the growth in the previous period include the need for quicker drug development, cost containment tactics, emphasis on key competencies, regulatory compliance prerequisites, and the globalization of clinical trials.
What Is the forecasted market size and growth rate for the preclinical cro market?
Strong expansion is projected for the preclinical CRO industry in the coming years, with estimations indicating a growth to $9.06 billion in 2029 at a 9.7% CAGR. Various factors contributing to this projected growth through the forecasting period include increased interest in personalized medicine, focus on rare diseases and orphan drugs, rising outsourcing trends within biopharmaceuticals, substantial emphasis on biomarker investigation, and a growing demand for real-world evidence. Key trends anticipated in the forecast timeframe include the incorporation of artificial intelligence (AI), continued expansion in oncology research, advancements in “omics” technologies, progress in in vitro and in vivo models, and cooperative efforts in translational research.
Get your preclinical cro market report here!
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report
What are the major factors driving growth in the preclinical cro market?
The surge in demand for preclinical trials is predicted to fuel the expansion of the preclinical CRO market in the forthcoming years. Preclinical trials denote any research conducted on a medical treatment or drug before it is tested on human subjects. These studies typically involve innovative medical devices, prescribed drugs, and diagnostics. The principal aims are to determine a starting safe dosage for initial human research and evaluate any possible product toxicity. Preclinical trials are pivotal in drug development, and their significance is growing due to heightened emphasis on the safety and effectiveness of new drugs. For example, in February 2024, IQVIA, a US-based firm active in health information technology and clinical research, reported that clinical development productivity increased in 2023. A total of 69 new active substances (NASs) were introduced globally in 2023, which was six more than the previous year. This included 24 first-in-class launches in the U.S. Thus, the burgeoning demand for preclinical trials is promoting the progress of the preclinical CRO market in the future.
What key areas define the segmentation of the global preclinical cro Market?
The preclinical CRO market covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies
6) By Other Services: Regulatory Consulting, Project Management, Data Management Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp
What are the top market players propelling the growth of the preclinical cro industry?
Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited
What are the key trends shaping the future of the preclinical cro market?
Technological innovation is an emerging trend in the preclinical CRO industry, with leading players embracing emerging technologies to maintain their market standing. An example of this is BenchSci, a Canadian AI solutions company that caters to preclinical R&D. In February 2023, the firm unveiled ASCEND, a comprehensive SaaS platform for preclinical drug discovery. The platform harnesses biological data to unravel the basic mechanisms of diseases, thereby expediting the preclinical phase of drug development. ASCEND leverages BenchSci’s machine learning capabilities to draw experimental data from secure internal and public sources. The software subsequently evaluates these experimental outcomes using curated ontology datasets, thereby generating a disease map founded on evidence, which elucidates the biological processes fueling various illnesses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10303
What regions are dominating the preclinical cro market growth?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Lymphocyte Modulator Global Market Report 2024
Tumor Infiltrating Lymphocytes Global Market Report 2024
Blood Group Typing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
